CMS Releases Final Medicare Advantage and Prescription Drug Plan Marketing Guidelines
Client Alert | less than 1 min read | 07.27.06
The Centers for Medicare & Medicaid Services released revised Medicare Advantage, MA-PD, Prescription Drug Plan and Medicare cost plan marketing guidelines on July 25, 2006.
We are reviewing the new guidelines for substantive changes from the previously released version.
Contacts
Insights
Client Alert | 4 min read | 04.08.26
Cosmetics Under the Microscope: FDA’s Expanding Regulatory Reach Under MoCRA
The Modernization of Cosmetics Regulation Act of 2022 (MoCRA) marked the most significant expansion of FDA’s authority over cosmetics in 80 years — and the agency is putting that authority to work. From the launch of a new adverse event reporting tool to forthcoming rules on fragrance allergens and good manufacturing practices (GMP), FDA is reshaping the regulatory landscape for manufacturers, packers, and distributors of cosmetic and personal care products.
Client Alert | 11 min read | 04.08.26
Client Alert | 3 min read | 04.07.26
Answering the Top Seven Questions About Pending Section 301 Deadlines
